Karyopharm Therapeutics (KPTI) Cash from Financing Activities (2012 - 2026)
Karyopharm Therapeutics' Cash from Financing Activities came in at $29.69 million for Q4 2025, compared with $680,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Cash from Financing Activities (2012 - 2026) Analysis & Trends
For FY2025, Karyopharm Therapeutics' Cash from Financing Activities was $30.05 million, down 27.8% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -29.5% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $41.65 million in FY2024, $1.12 million in FY2023 (-99.4%), $193.74 million in FY2022 (+163.1%) and $73.65 million in FY2021 (-57.2%).
- The Q4 2025 figure represents the highest quarterly Cash from Financing Activities since Q4 2022.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2022 (growth of 188.3%), and the weakest in Q4 2023 (a decline of 99.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Karyopharm Therapeutics | 578,759.99 | -265.00 Mn | 32.35 Mn | -898,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -898,000.00 |
| Mar 31, 2026 | 49.80 Mn |
| Dec 31, 2025 | 29.69 Mn |
| Jun 30, 2025 | 356,000.00 |
| Dec 31, 2024 | 680,000.00 |
| Dec 31, 2023 | 264,000.00 |
| Jun 30, 2023 | 860,000.00 |
| Dec 31, 2022 | 155.84 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 30.78 Mn |
| Dec 31, 2021 | 896,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 62.06 Mn |
| Mar 31, 2021 | 10.68 Mn |
| Dec 31, 2020 | 3.97 Mn |
| Sep 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 2.05 Mn |
| Mar 31, 2020 | 164.83 Mn |
| Dec 31, 2019 | 34.94 Mn |
API Access
Karyopharm Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();